Nting alloimmune and autoimmune disease. The FGL2 cRIIB pathway is also
Nting alloimmune and (��)-Zanubrutinib web autoimmune disease. The FGL2 cRIIB pathway is also known to be utilized by viruses and tumor cells to evade immune surveillance. Moving forward, therapies based…